SCHEMBL13065615

SCHEMBL13065615

CNc1ccc2nc3c(C(=O)O)c(-c4ccc(CC(=O)O)cc4)c(=O)c(O)c-3oc2c1

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HPSE Q9Y251 6/20 0.37
MEN1 O00255 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34
KMT2A Q03164 1/20 0.34
AURKA O14965 2/20 0.34
AURKB Q96GD4 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
HSD17B10 Q99714 1/20 0.34
KDR P35968 1/20 0.34
CASP3 P42574 1/20 0.33
SENP8 Q96LD8 1/20 0.33
SENP7 Q9BQF6 1/20 0.33
SENP6 Q9GZR1 1/20 0.33
GAA P10253 1/20 0.33
POLB P06746 1/20 0.33
PDE4B Q07343 3/20 0.32
TP53 P04637 1/20 0.32
MAPT P10636 1/20 0.32
PDE4D Q08499 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13065611 0.89 GPR119 (0.39) MEN1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL13065589 0.88 DHODH (0.40) MEN1NPC1RAB9AKMT2ACASP3
SCHEMBL16784715 0.86 TP53 (0.42) MEN1KMT2AHSD17B10POLBTP53
SCHEMBL13065623 0.84 MEN1 (0.41) MEN1NPC1RAB9AKMT2AAURKA
SCHEMBL13065740 0.84 LMNA (0.39) MEN1KMT2AGAAPOLBPDE4B
SCHEMBL13065590 0.80 MAPT (0.38) MEN1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL13065607 0.77 SLC16A3 (0.36) MEN1NPC1RAB9AKMT2AHSD17B10
SCHEMBL13065587 0.77 CASP3 (0.41) MEN1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL13065598 0.76 MEN1 (0.43) MEN1NPC1RAB9AKMT2ASMN1; SMN2
SCHEMBL16784744 0.76 PDE10A (0.40) MEN1NPC1RAB9AKMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9052324-B2 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. (US) 2015-06-09 US disclosed
US-20120322717-A9 Compounds and assays for controlling Wnt activity ENZO BIOCHEM, INC. 2012-12-20 US disclosed
US-20100298200-A1 Compounds and assays for controlling Wnt activity LIU DAKAI 2010-11-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120322717-A9 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 HPSE 1172/4885MEN1 3364/4885NPC1 2196/4885
US-20100298200-A1 Compounds and assays for controlling Wnt activity WNT1, WNT3A, WNT3 HPSE 1172/4885MEN1 3364/4885NPC1 2196/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.